Boston, MA—April 4, 2016—LEERINK Partners, a leading healthcare investment bank, announced that Joseph D’Amadeo has joined its Institutional Equities team as a Managing Director. Mr. D’Amadeo will be based in the firm’s New York office.
Mr. D’Amadeo brings 30 years of experience and expertise in institutional equity sales to LEERINK Partners. Most recently, he led and co-managed the Institutional Sales team at Barclays Investment Bank, where he served as Managing Director of Equity Research Sales. During his 17 years at Barclays, and formerly Lehman Brothers, Mr. D’Amadeo was widely recognized by both colleagues and peers for his capability to generate new business and maximize commercial outcomes for the firm.
“We are thrilled to welcome Joe to LEERINK Partners’ equities team,” said Rob Leerink, Senior Managing Director, Head of Institutional Equities. “Throughout his career, Joe has a demonstrated expertise in executing on equity sales strategies that deliver first-class client service and strong results, and we look forward to him bringing these skills to bear for LEERINK. With his experience across healthcare markets and extensive industry relationships, Joe will further our ability to serve our clients as their trusted partner.”
”I am excited to be joining a firm with such a differentiated platform and knowledge-led approach,” said Mr. D’Amadeo. “I look forward to further enhancing LEERINK’s strong industry and investor relationships and contributing to its continued success in delivering clients unique insights and high quality service.”
About LEERINK Partners
LEERINK Partners LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.leerink.com.